INTRODUCTION

59
Maintaining skeletal muscle mass during pathological conditions is critical for several 60 important health-related outcomes including preserved physical function, improved metabolic 61 profile, and reduced risk of mortality (19, 29, 38) . In males, a decrease in the production and/or 62 bioavailability of androgens that accompanies various pathological conditions, termed 63 hypogonadism, directly contributes to atrophy of the limb skeletal muscles by promoting the loss 64 of muscle protein (6, 10-12, 14, 25, 35, 42, 46) . In humans, the atrophy and loss of muscle 65 protein in the limb skeletal muscles is largely attributable to a reduction in muscle protein 66 synthesis and/or an increase in muscle protein breakdown (10-12, 35, 42) . While this is fairly 67 well established, the molecular mechanism(s) underlying the change in protein metabolism 68 remain controversial (32). This knowledge is needed to optimize the management of muscle 69 atrophy during hypogonadism, which includes the generation of androgen-independent therapies 70 for those that are contraindicated from androgen treatment.
71
Though the mechanisms by which androgens regulate protein metabolism and growth of 72 the limb skeletal muscle are still unclear, signaling through the mechanistic target of rapamycin 73 in complex 1 (mTORC1) has been implicated as an androgen-sensitive transducer underlying 74 these effects as mTORC1 can induce protein accretion and muscle growth through 75 phosphorylation of substrates including the 70 kD ribosomal protein S6 kinase 1 (p70S6K1) and 76 uncoordinated like kinase 1 (ULK1) (16, 18, 23 The overall experimental design for testing the role of rapamycin in the androgen-116 mediated growth of limb skeletal muscle is depicted in Fig. 1 . Following a 7-day acclimation 117 upon arrival to the animal facility, mice were randomized into four groups of equal body weight
118
(N =6/group). One group was subjected to sham surgery while the remaining groups were 119 subjected to castration surgery as previously described (39 
157
Thirty min post injection, the tibialis anterior (TA) was extracted and analyzed for activation of
158
Akt/mTORC1 signaling.
159
Protein Extraction and Western Blot Analysis
160
Western blotting was conducted as previously described (31). Whole muscle protein was 161 extracted by glass on glass homogenization in 10 volumes of buffer (10 µl/mg of muscle)
162
consisting of 50 mM HEPES (pH 7.4), 0.1% Triton-X 100, 4 mM EGTA, 10 mM EDTA, 15 mM 163 Na 4 P 2 O 7 , 100 mM β-glycerophosphate, 25 mM NaF, 5 mM Na 3 VO 4 , and 10 µl/ml protease 164 inhibitor cocktail (Sigma Aldrich, cat. #P8340). Muscle extract was centrifuged for 10 min at observed in control mice at any post-injection time point ( Fig. 2A & B) . insulin increased phosphorylation of Akt (Thr308) to a similar magnitude (Fig. 3A) . Insulin also 232 increased phosphorylation of p70S6K1 (Thr389) in control mice, but treatment with rapamycin 233 prevented this effect (Fig. 3B) . The insulin-induced phosphorylation of ULK1 (Ser757), an 234 mTORC1-substrate less sensitive to rapamycin (22), was also completely negated by rapamycin 235 (Fig. 3C) . Thus, the rapamycin pellets effectively inhibited mTORC1 signaling in skeletal 236 muscle for the duration of the experiment.
237
The effects of castration, androgen restoration, and rapamycin on body and tissue mass
238
All groups increased body mass throughout the experiment, although treatment with ND 239 led to a greater percent increase from their initial body mass ( (Table 3 ). This rapamycin-insensitive restoration of mass was due to accretion of muscle protein
253
( Fig. 4B) , which was further supported by a strong relationship between TA mass and muscle 254 protein content (Fig. 4C) . The androgen-mediated restoration of muscle mass and protein 255 content in previously castrated mice was due to muscle fiber growth as noted by the complete 256 restoration in muscle fiber cross sectional area and fiber frequency distribution, even with 257 rapamycin treatment (Fig. 4D, F-L) . Muscle fiber CSA variability was not affected by any 258 condition (Fig. 4E) . Together, these data suggest a negligible role for the rapamycin-sensitive 259 portion of mTORC1 in the androgen-mediated growth and accretion of protein within the TA. Significant difference compared to all other groups. Significance set at P < 0.05. 
